Reuven J. Viskoper

1.1k total citations
19 papers, 886 citations indexed

About

Reuven J. Viskoper is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Reuven J. Viskoper has authored 19 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Reuven J. Viskoper's work include Blood Pressure and Hypertension Studies (7 papers), Heart Rate Variability and Autonomic Control (4 papers) and Neuroscience and Neuropharmacology Research (2 papers). Reuven J. Viskoper is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Heart Rate Variability and Autonomic Control (4 papers) and Neuroscience and Neuropharmacology Research (2 papers). Reuven J. Viskoper collaborates with scholars based in Israel, United States and Switzerland. Reuven J. Viskoper's co-authors include Vincent Charlon, Yves Lacourcière, Henry Krum, M. Budde, Chaim Yosefy, Isaac Kobrin, Alberto Zanchetti, Giuseppe Mancia, Xavier Girerd and Sverre E. Kjeldsen and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Cardiology and Journal of Hypertension.

In The Last Decade

Reuven J. Viskoper

19 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reuven J. Viskoper Israel 11 574 357 251 170 133 19 886
Pablo Forte United Kingdom 12 316 0.6× 385 1.1× 179 0.7× 91 0.5× 133 1.0× 25 827
Roberto S. Cunha Brazil 16 678 1.2× 204 0.6× 197 0.8× 129 0.8× 92 0.7× 24 1.1k
Uran Onaka Japan 17 452 0.8× 269 0.8× 193 0.8× 182 1.1× 52 0.4× 34 810
Michael Böhm Germany 10 608 1.1× 248 0.7× 203 0.8× 180 1.1× 88 0.7× 18 1.3k
H Fukuzaki Japan 14 431 0.8× 222 0.6× 74 0.3× 172 1.0× 92 0.7× 48 845
Gerd Bönner Germany 17 470 0.8× 87 0.2× 247 1.0× 121 0.7× 118 0.9× 82 886
H. J. G. Bilo Netherlands 18 215 0.4× 197 0.6× 401 1.6× 136 0.8× 125 0.9× 43 991
T. Quesada Spain 17 332 0.6× 396 1.1× 127 0.5× 116 0.7× 56 0.4× 51 792
Roberto Della Bruna Switzerland 15 480 0.8× 140 0.4× 210 0.8× 337 2.0× 82 0.6× 30 734
M. A. Boim Brazil 9 354 0.6× 127 0.4× 170 0.7× 151 0.9× 57 0.4× 15 755

Countries citing papers authored by Reuven J. Viskoper

Since Specialization
Citations

This map shows the geographic impact of Reuven J. Viskoper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuven J. Viskoper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuven J. Viskoper more than expected).

Fields of papers citing papers by Reuven J. Viskoper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reuven J. Viskoper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuven J. Viskoper. The network helps show where Reuven J. Viskoper may publish in the future.

Co-authorship network of co-authors of Reuven J. Viskoper

This figure shows the co-authorship network connecting the top 25 collaborators of Reuven J. Viskoper. A scholar is included among the top collaborators of Reuven J. Viskoper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reuven J. Viskoper. Reuven J. Viskoper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yosefy, Chaim, et al.. (2016). [THE IMPACT OF A COMMUNITY INTERVENTION PROGRAM IN ISRAELI WORKSITES TO REDUCE THE RISK OF CARDIOVASCULAR DISEASES].. PubMed. 155(8). 485–489. 2 indexed citations
2.
Kjeldsen, Sverre E., Gordon T. McInnes, Giuseppe Mancia, et al.. (2008). Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial. Blood Pressure. 17(3). 170–177. 10 indexed citations
3.
Yosefy, Chaim, Gary Ginsberg, Reuven J. Viskoper, Dror Dicker, & Dov Gavish. (2007). Cost-utility analysis of a national project to reduce hypertension in Israel. Cost Effectiveness and Resource Allocation. 5(1). 16–16. 6 indexed citations
4.
Kjeldsen, Sverre E., Stevo Julius, Giuseppe Mancia, et al.. (2006). Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. Journal of Hypertension. 24(7). 1405–1412. 116 indexed citations
5.
6.
Magen, Eli, et al.. (2004). Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.. PubMed. 6(12). 742–6. 33 indexed citations
7.
Leibovitz, Eyal, et al.. (2003). Risk factor profile and achievement of treatment goals among hypertensive patients in general practice in Israel: baseline results from the Israeli Blood Pressure Control (IBPC) program.. PubMed. 5(10). 697–701. 2 indexed citations
8.
Viskoper, Reuven J.. (2003). Nonpharmacologic treatment of resistant hypertensives by Device-Guided slow breathing exercises. American Journal of Hypertension. 16(6). 484–487. 64 indexed citations
9.
Krum, Henry, Reuven J. Viskoper, Yves Lacourcière, M. Budde, & Vincent Charlon. (1998). The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension. New England Journal of Medicine. 338(12). 784–791. 449 indexed citations
10.
Viskoper, Reuven J., et al.. (1997). Verapamil and trandolapril alone and in fixed combination on 24-hour ambulatory blood pressure profiles of patients with moderate essential hypertension. Current Therapeutic Research. 58(6). 343–351. 9 indexed citations
11.
Massie, Barry M., Yves Lacourcière, Reuven J. Viskoper, A. J. J. Woittiez, & Isaac Kobrin. (1997). Mibefradil in the Treatment of Systemic Hypertension. The American Journal of Cardiology. 80(4). 27C–33C. 12 indexed citations
12.
Viskoper, Reuven J., et al.. (1997). Verapamil and trandolapril alone and in fixed combination in moderate essential hypertension: a multicenter, double-masked study. Current Therapeutic Research. 58(6). 331–342. 8 indexed citations
13.
Kobrin, Isaac, et al.. (1993). Effects of an Orally Active Renin Inhibitor, Ro 42-5892, in Patients With Essential Hypertension. American Journal of Hypertension. 6(5_Pt_1). 349–356. 36 indexed citations
14.
Wolf, Ronni, Danny Wolf, Reuven J. Viskoper, & Miriam Sandbank. (1985). Norwegian-type scabies mimicking contact dermatitis. Postgraduate Medicine. 78(1). 228–230. 18 indexed citations
15.
Schlesinger, M, Juri Kopolovic, Reuven J. Viskoper, & Noemi Ron. (1983). A Case of Familial Mediterranean Fever with Cutaneous Vasculitis and Immune Complex Nephritis: Light, Electron, and Immunofluorescent Study of Renal Biopsy. American Journal of Clinical Pathology. 80(4). 511–514. 29 indexed citations
16.
Viskoper, Reuven J., et al.. (1975). McArdle??s syndrome: the reaction to a fat-rich diet. The American Journal of the Medical Sciences. 269(2). 217–221. 14 indexed citations
17.
Viskoper, Reuven J., et al.. (1973). On the beneficial action of acetazolamide in hypokalemic periodic paralysis. The American Journal of the Medical Sciences. 266(2). 125–129. 5 indexed citations
18.
Viskoper, Reuven J., et al.. (1973). Acetazolamide treatment in hypokalemic periodic paralysis. The American Journal of the Medical Sciences. 266(2). 119–123. 8 indexed citations
19.
Viskoper, Reuven J.. (1971). Nerve Conduction Velocity in the Assessment of Hypertension. Archives of Internal Medicine. 128(4). 574–574. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Forte Breakdown of academic impact, for papers by Roberto S. Cunha Breakdown of academic impact, for papers by Uran Onaka Breakdown of academic impact, for papers by Michael Böhm Breakdown of academic impact, for papers by H Fukuzaki Breakdown of academic impact, for papers by Gerd Bönner Breakdown of academic impact, for papers by H. J. G. Bilo Breakdown of academic impact, for papers by T. Quesada Breakdown of academic impact, for papers by Roberto Della Bruna Breakdown of academic impact, for papers by M. A. Boim
Rankless by CCL
2026